Vaccines and perception of the pharmaceutical industry

Over the last decade there have been multiple controversies which have damaged the reputation of ‘Big Pharma’ in the eyes of the general public.

However, the pharmaceutical industry’s response to COVID-19 , and subsequent rapid vaccine development are now considered essential to securing a way out of cyclical lockdowns and reopening economies.

The “2020 Global pharma study” from Caliber affirms “Now, as the pubic eye turns towards Big Pharma for a vaccine for COVID-19, the industry has been given a rare opportunity to prove its relevance. If this opportunity is taken, a whole new relationship with society may follow: one that sees patients, employees, physicians, organizations and governments being more supportive and less critical. One that solidifies the pharmaceutical companies sector’s legitimacy, ensures its future success and enables it to fulfill its true role of improving lives and livelihoods.”

In January 2021, we have conducted an internal survey amongst 1,096 healthcare professionals working in the United Kingdom, Germany, France, Spain, and Italy. We asked our panel members if the rapid rollout of vaccines has helped to improve perceptions of the pharmaceutical industry and pharmaceutical companies.

Here is what the M3 Global Community thinks about this topic.

“Vaccines and perception of the pharmaceutical industry” is one of the many topics we cover, you can visit our available studies section and discover all the paid opportunities available for your specialty.

You can also learn more about what is healthcare market research and how to participate in medical research.

By joining M3 Global Research, you will be able to have your voice heard. Taking part in market research is easy and you will receive an incentive for your precious time.

We are looking for opinions from healthcare professionals as well as caregivers and the general public to improve future patient outcomes.

Would you like to receive the M3 Pulse directly to your inbox and take part in paid market research?

Join M3 Global Research

Share your opinion and get rewarded

Register as healthcare professional

1 comment

  1. My answer would be “if they choose collaboration over competition” because there is a huge number of pharmaceutical companies who only think about their business and not about people’s health, their major concern is getting profit out of their product irrespective of the side effects their products are causing to the people.

Leave a Reply

Join Today

Registration is free and only takes a few clicks

Panel Members

Check your available studies

latest posts

emerging respiratory treatments for lung cancer - cystic fibrosis - robotic navigation - gene-editing nanoparticles

Emerging Respiratory Treatments: Frontiers in Pulmonology

Emerging respiratory medicines and treatments, including robotic navigation and gene-editing nanoparticles, may significantly improve patient outcomes in the future for prevalent pulmonary diseases like lung cancer, cystic fibrosis, and chronic obstructive pulmonary disease.

Paid Studies About Medical Devices | M3 Guide

Real-World Evidence studies collect real-world data to evaluate the safety and performance of medical devices. This M3 Guide reveals how we conduct Real-World Evidence studies, how they contribute to better patient outcomes, and how healthcare professionals can get compensated.